High lysophosphatidylcholine acyltransferase 1 expression independently predicts high risk for biochemical recurrence in prostate cancers

Phospholipase PLA2G7, associated with aggressive prostate cancer, promotes prostate cancer cell migration and invasion and is inhibited by statins

(2015) Paula Vainio et al.   Oncotarget

Cancer statistics, 2013

(2013) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

CHD1 Is a 5q21 Tumor Suppressor Required for ERG Rearrangement in Prostate Cancer

(2013) L. Burkhardt et al.   CANCER RESEARCH

Genomic deletion of MAP3K7 at 6q12-22 is associated with early PSA recurrence in prostate cancer and absence of TMPRSS2:ERG fusions

(2013) Martina Kluth et al.   MODERN PATHOLOGY

Genomic Deletion of PTEN Is Associated with Tumor Progression and Early PSA Recurrence in ERG Fusion-Positive and Fusion-Negative Prostate Cancer

(2012) Antje Krohn et al.   AMERICAN JOURNAL OF PATHOLOGY

Upgrading and Downgrading of Prostate Cancer from Biopsy to Radical Prostatectomy: Incidence and Predictive Factors Using the Modified Gleason Grading System and Factoring in Tertiary Grades

(2012) Jonathan I. Epstein et al.   EUROPEAN UROLOGY

Lipid metabolism in cancer

(2012) Claudio R. Santos et al.   FEBS Journal

Loss of pSer2448-mTOR expression is linked to adverse prognosis and tumor progression inERG-fusion-positive cancers

(2012) Julia Müller et al.   INTERNATIONAL JOURNAL OF CANCER

Cysteine-rich secretory protein 3 overexpression is linked to a subset of PTEN-deleted ERG fusion-positive prostate cancers with early biochemical recurrence

(2012) Katharina Grupp et al.   MODERN PATHOLOGY

Lipids and prostate cancer

(2012) Janel Suburu et al.   PROSTAGLANDINS & OTHER LIPID MEDIATORS

Arachidonic Acid Pathway Members PLA2G7, HPGD, EPHX2, and CYP4F8 Identified as Putative Novel Therapeutic Targets in Prostate Cancer

(2011) Paula Vainio et al.   AMERICAN JOURNAL OF PATHOLOGY

Hypoxia-inducible factor-1 (HIF-1) promotes LDL and VLDL uptake through inducing VLDLR under hypoxia

(2011) Guo-Min Shen et al.   BIOCHEMICAL JOURNAL

TMPRSS2-ERG -specific transcriptional modulation is associated with prostate cancer biomarkers and TGF-β signaling

(2011) Jan C Brase et al.   BMC CANCER

15-Lipoxygenase-1 as a tumor suppressor gene in colon cancer: is the verdict in?

(2011) Sun IL Lee et al.   CANCER AND METASTASIS REVIEWS

ERG Status Is Unrelated to PSA Recurrence in Radically Operated Prostate Cancer in the Absence of Antihormonal Therapy

(2011) Sarah Minner et al.   CLINICAL CANCER RESEARCH

The expression level of lysophosphatidylcholine acyltransferase 1 (LPCAT1) correlates to the progression of prostate cancer

(2011) Xinchun Zhou et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

Low activated leukocyte cell adhesion molecule expression is associated with advanced tumor stage and early prostate-specific antigen relapse in prostate cancer

(2011) Sarah Minner et al.   HUMAN PATHOLOGY

SorLA regulates the activity of lipoprotein lipase by intracellular trafficking

(2011) S. C. Klinger et al.   JOURNAL OF CELL SCIENCE

Common Gene Rearrangements in Prostate Cancer

(2011) Mark A. Rubin et al.   JOURNAL OF CLINICAL ONCOLOGY

The genomic complexity of primary human prostate cancer

(2011) Michael F. Berger et al.   NATURE

Emerging roles for phospholipase A2 enzymes in cancer

(2010) Kieran F. Scott et al.   BIOCHIMIE

Integrative Genomic Profiling of Human Prostate Cancer

(2010) Barry S. Taylor et al.   CANCER CELL

Fatty acid synthase as a potential therapeutic target in cancer

(2010) Richard Flavin et al.   Future Oncology

LPCAT1 regulates surfactant phospholipid synthesis and is required for transitioning to air breathing in mice

(2010) James P. Bridges et al.   JOURNAL OF CLINICAL INVESTIGATION

Ets-1 Regulates Energy Metabolism in Cancer Cells

(2010) Meghan L. Verschoor et al.   PLoS One

High level PSMA expression is associated with early psa recurrence in surgically treated prostate cancer

(2010) Sarah Minner et al.   PROSTATE

A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice

(2009) Long Cheng et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Fine-tuning the lipogenic/lipolytic balance to optimize the metabolic requirements of cancer cell growth: Molecular mechanisms and therapeutic perspectives

(2009) Javier A. Menendez   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Lysophospholipids stimulate prostate cancer cell migration via TRPV2 channel activation

(2009) Michaël Monet et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

Novel Lipogenic Enzyme ELOVL7 Is Involved in Prostate Cancer Growth through Saturated Long-Chain Fatty Acid Metabolism

(2009) K. Tamura et al.   CANCER RESEARCH

Chromosome 8p Deletions and 8q Gains are Associated with Tumor Progression and Poor Prognosis in Prostate Cancer

(2009) A. T. El Gammal et al.   CLINICAL CANCER RESEARCH

Integration ofERGgene mapping and gene-expression profiling identifies distinct categories of human prostate cancer

(2008) Sameer Jhavar et al.   BJU INTERNATIONAL

Tumour growth fraction measured by immunohistochemical staining of Ki67 is an independent prognostic factor in preoperative prostate biopsies with small-volume or low-grade prostate cancer

(2008) Tobias Zellweger et al.   INTERNATIONAL JOURNAL OF CANCER

Identification of a Novel Noninflammatory Biosynthetic Pathway of Platelet-activating Factor

(2008) Takeshi Harayama et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Lysophosphatidylcholine acyltransferase 1 (LPCAT1) overexpression in human colorectal cancer

(2008) Francisco Mansilla et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Clinical significance of p53 alterations in surgically treated prostate cancers

(2008) Thorsten Schlomm et al.   MODERN PATHOLOGY